KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 77 filers reported holding KALA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $37,000 | -9.8% | 5,500 | 0.0% | 0.01% | -30.8% |
| Q3 2020 | $41,000 | -29.3% | 5,500 | 0.0% | 0.01% | -40.9% |
| Q2 2020 | $58,000 | +20.8% | 5,500 | 0.0% | 0.02% | 0.0% |
| Q1 2020 | $48,000 | +140.0% | 5,500 | 0.0% | 0.02% | +175.0% |
| Q4 2019 | $20,000 | -4.8% | 5,500 | 0.0% | 0.01% | -11.1% |
| Q3 2019 | $21,000 | -41.7% | 5,500 | 0.0% | 0.01% | -43.8% |
| Q2 2019 | $36,000 | -21.7% | 5,500 | 0.0% | 0.02% | -33.3% |
| Q1 2019 | $46,000 | – | 5,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,704,849 | $9,036,000 | 6.19% |
| RA Capital Management | 10,874,613 | $57,635,000 | 0.92% |
| Mesirow Financial Investment Management, Inc. | 42,104 | $223,000 | 0.57% |
| ACT CAPITAL MANAGEMENT, LLC | 190,000 | $1,007,000 | 0.52% |
| Samsara BioCapital, LLC | 601,162 | $3,186,000 | 0.39% |
| Orbimed Advisors | 5,465,030 | $28,965,000 | 0.29% |
| ALGERT GLOBAL LLC | 72,490 | $384,000 | 0.13% |
| Knights of Columbus Asset Advisors LLC | 236,257 | $1,252,000 | 0.12% |
| Bridgefront Capital, LLC | 47,569 | $252,000 | 0.10% |
| Matisse Capital | 56,100 | $297,000 | 0.09% |